Macom Technology Surges on Record Earnings and Outlook

Macom Technology Solutions ((MTSI)) has held its Q2 earnings call. Read on for the main highlights of the call.

Macom Technology Solutions’ latest earnings call struck a decidedly upbeat tone, underscoring strong operational momentum, record bookings and expanding margins. Management balanced this optimism with a sober acknowledgment of execution risks around inventory, supply chain dependencies and the timing of new technologies, but insisted that cash strength and disciplined spending leave the company well positioned.

Record Revenue and Broad-Based Growth

Macom reported Q2 FY2026 revenue of $289.0 million, up 6.4% sequentially and more than 22% year over year. Growth was broad-based, with Data Center, Industrial & Defense and Telecom all contributing, signaling that demand strength extends beyond a single end market.

Largest Bookings in Company History

Bookings were a standout, with a book-to-bill ratio of 1.5:1 and the largest quarterly bookings in the company’s history. Management noted that about 18% of revenue came from orders booked and shipped within the quarter, while overall backlog reached a record level, providing strong visibility.

Data Center Momentum Accelerates

Data Center revenue reached $98.2 million, rising roughly 14.5% sequentially as cloud and AI demand fueled uptake. Macom materially lifted its FY2026 Data Center growth base case from the mid-30s/40% range to above 60%, citing strong traction in 800G and 1.6T products and an expanding addressable market.

Margins and Profitability on an Uptrend

Profitability continued to improve, with adjusted gross profit of $169 million translating to a 58.5% gross margin, up 90 basis points sequentially. Adjusted operating income rose to $80.5 million, yielding a 27.8% operating margin and marking significant leverage as revenue scales.

EPS Growth Streak Continues

Adjusted net income climbed to $84.3 million, up about 7.8% from the prior quarter. Adjusted EPS increased to $1.09 from $1.02, extending Macom’s streak of sequential EPS growth to 11 consecutive quarters and reinforcing the narrative of consistent execution.

Robust Cash Generation and Balance Sheet

The company ended the quarter with $664.9 million in cash, cash equivalents and short-term investments, underscoring ample financial flexibility. Operating cash flow reached approximately $78.7 million, up $35.8 million sequentially, and management reiterated expectations for full-year FY2026 operating cash flow to exceed $300 million.

Deleveraging Through Convertible Note Repayment

Macom continued to deleverage, repaying $161 million of 2026 convertible notes during the quarter, which modestly reduced net interest income. After this move, net cash stood at roughly $325 million when comparing cash to the remaining convertible notes, further strengthening the balance sheet.

Fabs Ramp Capacity and Efficiency

On the operations front, the company highlighted yield and throughput improvements across its fabs, including higher wafer output and shorter cycle times in North Carolina. Facilities in Massachusetts and Lowell are adding capacity and processes for GaN and indium phosphide, supported by a FY2026 CapEx plan of $55–65 million aimed at incremental expansion.

Strategic Supply Chain Investments

To bolster long-term supply resilience, Macom participated in a roughly GBP45 million fundraising for IQE and signed a long-term supply agreement. This move is intended to secure epitaxial and indium phosphide materials, although management cautioned that the transaction remains subject to regulatory approvals and a shareholder vote.

Rising R&D-Driven Operating Expenses

Adjusted operating expenses rose to $88.6 million, led by $59.1 million in R&D and $29.5 million in SG&A, reflecting ongoing investment in innovation and talent. Management signaled that OpEx will continue to grow with the business as R&D remains a strategic priority despite near-term margin pressure.

Inventory Build to Support Future Demand

Inventories increased to $252.2 million from $238.9 million, with inventory turns at 1.9x, indicating more capital tied up in work-in-process and fabs. Macom framed this as a deliberate move to support production ramps, though it also acknowledged the working capital constraints and the need to manage levels carefully.

Delay in CW Laser Revenue Contribution

Management updated investors on continuous-wave laser technology, noting encouraging performance but unfinished process-of-record and reliability qualifications. As a result, they advised against modeling meaningful CW laser revenue for FY2026 or likely FY2027, shifting expectations toward potential contribution in FY2027 or FY2028.

Material and Supply Chain Risk Factors

The company highlighted potential supply pressures in critical materials such as indium phosphide and silicon carbide, even as it moves to secure key partners. Regulatory and execution risks around strategic supply initiatives, including the IQE deal, remain a watch point for investors tracking long-term capacity.

Market Concentration and Timing Considerations

Macom’s results are increasingly tied to Data Center and hyperscaler spending cycles, a key growth engine but also a source of volatility. Management also noted that while bookings and backlog are robust, revenue recognition is limited to the next 12 months, creating timing exposure as large orders are delivered.

Delayed Benefits from Competitor Exits

In the RF power market, the firm sees future upside from competitor exits but cautioned that these benefits will take time to reach the bottom line. Design wins and ramps are expected to contribute more meaningfully from FY2027, leaving limited impact on FY2026 results despite the long-term opportunity.

Minor Impact from Lower Interest Income

Adjusted net interest income slipped modestly to $6.5 million, a decline of about $0.2 million sequentially tied in part to debt repayment. Management downplayed the impact, positioning it as a manageable trade-off given the strengthened balance sheet and lower leverage.

Regulatory Uncertainty Around Strategic Deals

The strategic supply agreement and investment with IQE are still subject to regulatory approvals and a shareholder vote expected within 30 to 60 days. This introduces some execution risk to Macom’s supply-security plans, though the company expressed confidence in the long-term benefits if the deal closes.

Guidance Signals Strong Near-Term Momentum

Looking ahead to Q3, Macom guided revenue between $331 million and $339 million, implying solid sequential growth across all three end markets. The company expects Data Center revenue to grow around 35% sequentially, Industrial & Defense about 10% and Telecom at a low single-digit pace, with adjusted gross margin of 59–60%, adjusted operating margin around 30% and EPS of $1.31–1.37.

Macom’s earnings call painted the picture of a company hitting new highs on revenue, bookings and profitability while investing aggressively for future growth. For investors, the key messages were accelerating Data Center momentum, disciplined balance sheet management and a candid acknowledgment of execution and supply risks, leaving the overall story skewed firmly toward opportunity.